BIOMAT Database Logo BIOMAT Database Logo

Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide. 1998

R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
Department of Pharmacological Sciences and Experimental Medicine, University of Camerino, Italy.

Intracerebroventricular (i.c.v.) injection of tachykinin (TK) NK-3 receptor agonists inhibits alcohol intake in genetically selected alcohol-preferring rats. The present study investigated the mechanism of action by which the selective TK NK-3 receptor agonist aminosenktide (NH2-SENK) attenuates ethanol intake in Marchigian Sardinian alcohol-preferring (msP) rats. The effect of NH2-SENK was studied by i.c.v. injection in the conditioned taste aversion (CTA) and in the conditioned place preference (CPP) paradigms; moreover, the effect of NH2-SENK on blood alcohol levels (BAL) following intragastric ethanol administration was investigated. The i.c.v. dose of 125 ng/rat of NH2-SENK, that markedly reduces ethanol intake, did not modify BAL, nor did it increase the CTA induced by intraperitoneal injection of ethanol, 1 g/kg body weight. These findings suggest that the effect of NH2-SENK on alcohol consumption is not related to modification of the pharmacokinetics of ethanol, nor to increase of the aversive properties of ethanol. On the other hand, the same i.c.v. dose of NH2-SENK evoked a pronounced and statistically significant CPP. This finding indicates that the TK NK-3 receptor agonist NH2-SENK possesses rewarding properties in msP rats and suggests that its inhibitory effect on ethanol consumption may be due to substitution of the rewarding properties of ethanol, thus making its consumption redundant.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002755 Choice Behavior The act of making a selection among two or more alternatives, usually after a period of deliberation. Approach Behavior,Approach Behaviors,Behavior, Approach,Behavior, Choice,Behaviors, Approach,Behaviors, Choice,Choice Behaviors
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic

Related Publications

R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
Antidiuretic action of tachykinin NK-3 receptor in the rat paraventricular nucleus.
December 1996, Brain research,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
A potent and selective agonist for NK-2 tachykinin receptor.
January 1989, Peptides,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.
September 1993, Neuroscience letters,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
Tachykinin NK(3)receptor involvement in anxiety.
April 1999, Neuropeptides,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
Inhibitory role on gastric secretion of a central NK-3 tachykinin receptor agonist, senktide.
January 1991, Peptides,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
The mechanism of central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the hypothalamus in rats.
July 1993, Regulatory peptides,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist.
November 1995, Brain research,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
June 1988, British journal of pharmacology,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat.
January 2000, Life sciences,
R Ciccocioppo, and I Panocka, and C Polidori, and R Froldi, and S Angeletti, and M Massi
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.
February 2001, European journal of pharmacology,
Copied contents to your clipboard!